aluates Reports

$ 0.0

Automative

Global Exosome Therapy Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-6M13880

Global Exosome Therapy Market Research Report 2023

BUY CHAPTERS

Global Exosome Therapy Market Research Report 2025

Code: QYRE-Auto-6M13880

Report

February 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

United Therapeutics Corporation

Codiak BioSciences

Engex

Esperite Group

Aruna Biomedical

Evox Therapeutics

NeurExo Sciences

Tavec Pharmaceuticals

Aegle Therapeutics

Avalon GloboCare

AlligatorBioscience

Capricor Therapeutics

Stem Cell Medicine

CellTex Therapeutics

Exosome Therapy Market Size

The global market for Exosome Therapy was valued at US$ 2044 million in the year 2024 and is projected to reach a revised size of US$ 3076 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Exosome Therapy Market

Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Exosome Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Therapy.

The Exosome Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Exosome Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Exosome Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Exosome Therapy Market Report

Report Metric	Details
Report Name	Exosome Therapy Market
Accounted market size in year	US$ 2044 million
Forecasted market size in 2031	US$ 3076 million
CAGR	6.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Direct Treatment Drug Delivery Vehicle
Segment by Application	Hospital Clinic Research Institutions
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	United Therapeutics Corporation, Codiak BioSciences, EngEx™, Esperite Group, ArunA Biomedical, Evox Therapeutics, NeurExo Sciences, Tavec Pharmaceuticals, AEGLE Therapeutics, Avalon GloboCare, AlligatorBioscience, Capricor Therapeutics, Stem Cell Medicine, CellTex Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Exosome Therapy Market growing?

Ans: The Exosome Therapy Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Exosome Therapy Market size in 2031?

Ans: The Exosome Therapy Market size in 2031 will be US$ 3076 million.

Who are the main players in the Exosome Therapy Market report?

Ans: The main players in the Exosome Therapy Market are United Therapeutics Corporation, Codiak BioSciences, EngEx™, Esperite Group, ArunA Biomedical, Evox Therapeutics, NeurExo Sciences, Tavec Pharmaceuticals, AEGLE Therapeutics, Avalon GloboCare, AlligatorBioscience, Capricor Therapeutics, Stem Cell Medicine, CellTex Therapeutics

What are the Application segmentation covered in the Exosome Therapy Market report?

Ans: The Applications covered in the Exosome Therapy Market report are Hospital, Clinic, Research Institutions

What are the Type segmentation covered in the Exosome Therapy Market report?

Ans: The Types covered in the Exosome Therapy Market report are Direct Treatment, Drug Delivery Vehicle

Recommended Reports

Exosome & Cell Therapy

RNA & Gene Therapeutics

Cancer & Disease Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Exosome Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Direct Treatment

1.2.3 Drug Delivery Vehicle

1.3 Market by Application

1.3.1 Global Exosome Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Research Institutions

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Exosome Therapy Market Perspective (2020-2031)

2.2 Global Exosome Therapy Growth Trends by Region

2.2.1 Global Exosome Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Exosome Therapy Historic Market Size by Region (2020-2025)

2.2.3 Exosome Therapy Forecasted Market Size by Region (2026-2031)

2.3 Exosome Therapy Market Dynamics

2.3.1 Exosome Therapy Industry Trends

2.3.2 Exosome Therapy Market Drivers

2.3.3 Exosome Therapy Market Challenges

2.3.4 Exosome Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Exosome Therapy Players by Revenue

3.1.1 Global Top Exosome Therapy Players by Revenue (2020-2025)

3.1.2 Global Exosome Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Exosome Therapy Revenue

3.4 Global Exosome Therapy Market Concentration Ratio

3.4.1 Global Exosome Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapy Revenue in 2024

3.5 Global Key Players of Exosome Therapy Head office and Area Served

3.6 Global Key Players of Exosome Therapy, Product and Application

3.7 Global Key Players of Exosome Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Exosome Therapy Breakdown Data by Type

4.1 Global Exosome Therapy Historic Market Size by Type (2020-2025)

4.2 Global Exosome Therapy Forecasted Market Size by Type (2026-2031)

5 Exosome Therapy Breakdown Data by Application

5.1 Global Exosome Therapy Historic Market Size by Application (2020-2025)

5.2 Global Exosome Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Exosome Therapy Market Size (2020-2031)

6.2 North America Exosome Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Exosome Therapy Market Size by Country (2020-2025)

6.4 North America Exosome Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Exosome Therapy Market Size (2020-2031)

7.2 Europe Exosome Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Exosome Therapy Market Size by Country (2020-2025)

7.4 Europe Exosome Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Exosome Therapy Market Size (2020-2031)

8.2 Asia-Pacific Exosome Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Exosome Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Exosome Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Exosome Therapy Market Size (2020-2031)

9.2 Latin America Exosome Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Exosome Therapy Market Size by Country (2020-2025)

9.4 Latin America Exosome Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Exosome Therapy Market Size (2020-2031)

10.2 Middle East & Africa Exosome Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Exosome Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Exosome Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 United Therapeutics Corporation

11.1.1 United Therapeutics Corporation Company Details

11.1.2 United Therapeutics Corporation Business Overview

11.1.3 United Therapeutics Corporation Exosome Therapy Introduction

11.1.4 United Therapeutics Corporation Revenue in Exosome Therapy Business (2020-2025)

11.1.5 United Therapeutics Corporation Recent Development

11.2 Codiak BioSciences

11.2.1 Codiak BioSciences Company Details

11.2.2 Codiak BioSciences Business Overview

11.2.3 Codiak BioSciences Exosome Therapy Introduction

11.2.4 Codiak BioSciences Revenue in Exosome Therapy Business (2020-2025)

11.2.5 Codiak BioSciences Recent Development

11.3 EngEx™

11.3.1 EngEx™ Company Details

11.3.2 EngEx™ Business Overview

11.3.3 EngEx™ Exosome Therapy Introduction

11.3.4 EngEx™ Revenue in Exosome Therapy Business (2020-2025)

11.3.5 EngEx™ Recent Development

11.4 Esperite Group

11.4.1 Esperite Group Company Details

11.4.2 Esperite Group Business Overview

11.4.3 Esperite Group Exosome Therapy Introduction

11.4.4 Esperite Group Revenue in Exosome Therapy Business (2020-2025)

11.4.5 Esperite Group Recent Development

11.5 ArunA Biomedical

11.5.1 ArunA Biomedical Company Details

11.5.2 ArunA Biomedical Business Overview

11.5.3 ArunA Biomedical Exosome Therapy Introduction

11.5.4 ArunA Biomedical Revenue in Exosome Therapy Business (2020-2025)

11.5.5 ArunA Biomedical Recent Development

11.6 Evox Therapeutics

11.6.1 Evox Therapeutics Company Details

11.6.2 Evox Therapeutics Business Overview

11.6.3 Evox Therapeutics Exosome Therapy Introduction

11.6.4 Evox Therapeutics Revenue in Exosome Therapy Business (2020-2025)

11.6.5 Evox Therapeutics Recent Development

11.7 NeurExo Sciences

11.7.1 NeurExo Sciences Company Details

11.7.2 NeurExo Sciences Business Overview

11.7.3 NeurExo Sciences Exosome Therapy Introduction

11.7.4 NeurExo Sciences Revenue in Exosome Therapy Business (2020-2025)

11.7.5 NeurExo Sciences Recent Development

11.8 Tavec Pharmaceuticals

11.8.1 Tavec Pharmaceuticals Company Details

11.8.2 Tavec Pharmaceuticals Business Overview

11.8.3 Tavec Pharmaceuticals Exosome Therapy Introduction

11.8.4 Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2020-2025)

11.8.5 Tavec Pharmaceuticals Recent Development

11.9 AEGLE Therapeutics

11.9.1 AEGLE Therapeutics Company Details

11.9.2 AEGLE Therapeutics Business Overview

11.9.3 AEGLE Therapeutics Exosome Therapy Introduction

11.9.4 AEGLE Therapeutics Revenue in Exosome Therapy Business (2020-2025)

11.9.5 AEGLE Therapeutics Recent Development

11.10 Avalon GloboCare

11.10.1 Avalon GloboCare Company Details

11.10.2 Avalon GloboCare Business Overview

11.10.3 Avalon GloboCare Exosome Therapy Introduction

11.10.4 Avalon GloboCare Revenue in Exosome Therapy Business (2020-2025)

11.10.5 Avalon GloboCare Recent Development

11.11 AlligatorBioscience

11.11.1 AlligatorBioscience Company Details

11.11.2 AlligatorBioscience Business Overview

11.11.3 AlligatorBioscience Exosome Therapy Introduction

11.11.4 AlligatorBioscience Revenue in Exosome Therapy Business (2020-2025)

11.11.5 AlligatorBioscience Recent Development

11.12 Capricor Therapeutics

11.12.1 Capricor Therapeutics Company Details

11.12.2 Capricor Therapeutics Business Overview

11.12.3 Capricor Therapeutics Exosome Therapy Introduction

11.12.4 Capricor Therapeutics Revenue in Exosome Therapy Business (2020-2025)

11.12.5 Capricor Therapeutics Recent Development

11.13 Stem Cell Medicine

11.13.1 Stem Cell Medicine Company Details

11.13.2 Stem Cell Medicine Business Overview

11.13.3 Stem Cell Medicine Exosome Therapy Introduction

11.13.4 Stem Cell Medicine Revenue in Exosome Therapy Business (2020-2025)

11.13.5 Stem Cell Medicine Recent Development

11.14 CellTex Therapeutics

11.14.1 CellTex Therapeutics Company Details

11.14.2 CellTex Therapeutics Business Overview

11.14.3 CellTex Therapeutics Exosome Therapy Introduction

11.14.4 CellTex Therapeutics Revenue in Exosome Therapy Business (2020-2025)

11.14.5 CellTex Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

United Therapeutics Corporation

Codiak BioSciences

Engex

Esperite Group

Aruna Biomedical

Evox Therapeutics

NeurExo Sciences

Tavec Pharmaceuticals

Aegle Therapeutics

Avalon GloboCare

AlligatorBioscience

Capricor Therapeutics

Stem Cell Medicine

CellTex Therapeutics

List of Tables

Table 1. Global Exosome Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Direct Treatment

Table 3. Key Players of Drug Delivery Vehicle

Table 4. Global Exosome Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Exosome Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Exosome Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Exosome Therapy Market Share by Region (2020-2025)

Table 8. Global Exosome Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Exosome Therapy Market Share by Region (2026-2031)

Table 10. Exosome Therapy Market Trends

Table 11. Exosome Therapy Market Drivers

Table 12. Exosome Therapy Market Challenges

Table 13. Exosome Therapy Market Restraints

Table 14. Global Exosome Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Exosome Therapy Market Share by Players (2020-2025)

Table 16. Global Top Exosome Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2024)

Table 17. Ranking of Global Top Exosome Therapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Exosome Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Exosome Therapy, Headquarters and Area Served

Table 20. Global Key Players of Exosome Therapy, Product and Application

Table 21. Global Key Players of Exosome Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Exosome Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Exosome Therapy Revenue Market Share by Type (2020-2025)

Table 25. Global Exosome Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Exosome Therapy Revenue Market Share by Type (2026-2031)

Table 27. Global Exosome Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Exosome Therapy Revenue Market Share by Application (2020-2025)

Table 29. Global Exosome Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Exosome Therapy Revenue Market Share by Application (2026-2031)

Table 31. North America Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Exosome Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Exosome Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Exosome Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Exosome Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Exosome Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Exosome Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Exosome Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Exosome Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Exosome Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Exosome Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Exosome Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. United Therapeutics Corporation Company Details

Table 47. United Therapeutics Corporation Business Overview

Table 48. United Therapeutics Corporation Exosome Therapy Product

Table 49. United Therapeutics Corporation Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 50. United Therapeutics Corporation Recent Development

Table 51. Codiak BioSciences Company Details

Table 52. Codiak BioSciences Business Overview

Table 53. Codiak BioSciences Exosome Therapy Product

Table 54. Codiak BioSciences Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 55. Codiak BioSciences Recent Development

Table 56. EngEx™ Company Details

Table 57. EngEx™ Business Overview

Table 58. EngEx™ Exosome Therapy Product

Table 59. EngEx™ Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 60. EngEx™ Recent Development

Table 61. Esperite Group Company Details

Table 62. Esperite Group Business Overview

Table 63. Esperite Group Exosome Therapy Product

Table 64. Esperite Group Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 65. Esperite Group Recent Development

Table 66. ArunA Biomedical Company Details

Table 67. ArunA Biomedical Business Overview

Table 68. ArunA Biomedical Exosome Therapy Product

Table 69. ArunA Biomedical Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 70. ArunA Biomedical Recent Development

Table 71. Evox Therapeutics Company Details

Table 72. Evox Therapeutics Business Overview

Table 73. Evox Therapeutics Exosome Therapy Product

Table 74. Evox Therapeutics Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 75. Evox Therapeutics Recent Development

Table 76. NeurExo Sciences Company Details

Table 77. NeurExo Sciences Business Overview

Table 78. NeurExo Sciences Exosome Therapy Product

Table 79. NeurExo Sciences Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 80. NeurExo Sciences Recent Development

Table 81. Tavec Pharmaceuticals Company Details

Table 82. Tavec Pharmaceuticals Business Overview

Table 83. Tavec Pharmaceuticals Exosome Therapy Product

Table 84. Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 85. Tavec Pharmaceuticals Recent Development

Table 86. AEGLE Therapeutics Company Details

Table 87. AEGLE Therapeutics Business Overview

Table 88. AEGLE Therapeutics Exosome Therapy Product

Table 89. AEGLE Therapeutics Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 90. AEGLE Therapeutics Recent Development

Table 91. Avalon GloboCare Company Details

Table 92. Avalon GloboCare Business Overview

Table 93. Avalon GloboCare Exosome Therapy Product

Table 94. Avalon GloboCare Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 95. Avalon GloboCare Recent Development

Table 96. AlligatorBioscience Company Details

Table 97. AlligatorBioscience Business Overview

Table 98. AlligatorBioscience Exosome Therapy Product

Table 99. AlligatorBioscience Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 100. AlligatorBioscience Recent Development

Table 101. Capricor Therapeutics Company Details

Table 102. Capricor Therapeutics Business Overview

Table 103. Capricor Therapeutics Exosome Therapy Product

Table 104. Capricor Therapeutics Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 105. Capricor Therapeutics Recent Development

Table 106. Stem Cell Medicine Company Details

Table 107. Stem Cell Medicine Business Overview

Table 108. Stem Cell Medicine Exosome Therapy Product

Table 109. Stem Cell Medicine Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 110. Stem Cell Medicine Recent Development

Table 111. CellTex Therapeutics Company Details

Table 112. CellTex Therapeutics Business Overview

Table 113. CellTex Therapeutics Exosome Therapy Product

Table 114. CellTex Therapeutics Revenue in Exosome Therapy Business (2020-2025) & (US$ Million)

Table 115. CellTex Therapeutics Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Exosome Therapy Picture

Figure 2. Global Exosome Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Exosome Therapy Market Share by Type: 2024 VS 2031

Figure 4. Direct Treatment Features

Figure 5. Drug Delivery Vehicle Features

Figure 6. Global Exosome Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Exosome Therapy Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Research Institutions Case Studies

Figure 11. Exosome Therapy Report Years Considered

Figure 12. Global Exosome Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Exosome Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Exosome Therapy Market Share by Region: 2024 VS 2031

Figure 15. Global Exosome Therapy Market Share by Players in 2024

Figure 16. Global Top Exosome Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Exosome Therapy Revenue in 2024

Figure 18. North America Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Exosome Therapy Market Share by Country (2020-2031)

Figure 20. United States Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Exosome Therapy Market Share by Country (2020-2031)

Figure 24. Germany Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Exosome Therapy Market Share by Region (2020-2031)

Figure 32. China Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Exosome Therapy Market Share by Country (2020-2031)

Figure 40. Mexico Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Exosome Therapy Market Share by Country (2020-2031)

Figure 44. Turkey Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Exosome Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. United Therapeutics Corporation Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 48. Codiak BioSciences Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 49. EngEx™ Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 50. Esperite Group Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 51. ArunA Biomedical Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 52. Evox Therapeutics Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 53. NeurExo Sciences Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 54. Tavec Pharmaceuticals Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 55. AEGLE Therapeutics Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 56. Avalon GloboCare Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 57. AlligatorBioscience Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 58. Capricor Therapeutics Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 59. Stem Cell Medicine Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 60. CellTex Therapeutics Revenue Growth Rate in Exosome Therapy Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Exosome Therapy Technology Market Research Report 2025

Global Exosome Therapeutics and Diagnostics Market Research Report 2024

Diagnostic Exosome Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Exosome Diagnostic and Therapeutic Market Insights Forecast to 2030

Global Exosome Technologies Market Research Report 2025

Global Exosome Therapeutics Market Research Report 2024

Global Medicinal Exosomes Market Research Report 2024

Global Exosome Detection and Diagnosis Market Research Report 2024

Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2025

Global Exosome Research Market Research Report 2024

Global Extracellular Vesicle Therapy Market Research Report 2024

Global Exosome Manufacturing Service Market Research Report 2024

Global Exosome Service Market Research Report 2025

Global Pancreatic and Bile Duct Cancer Drug Market Insights Forecast to 2030

Exosome Research Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Plant Exosomes Market Research Report 2025

Global Exosomes Skincare Market Research Report 2025

Global Exosome Isolation Kits Market Research Report 2025

Global Exosome Analyzers Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions